Stay updated with breaking news from Major Statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On December 26, 2023, the Food and Drug Administration’s Office of Prescription Drug Promotion (“OPDP”) issued a Questions and Answers Guidance for industry titled “Direct-to-Consumer...
As 2023 came to a close, the U.S. Food and Drug Administration issued a new rule on direct-to-consumer prescription drug advertising along with business guidance to assist companies with compliance.
FDA issued a new Q&A Guidance, which provides helpful context and examples for compliance with its November Direct-to-Consumer Clear...
On December 26, 2023, the Food and Drug Administration (FDA) released a Small Entity Compliance Guide Final Guidance Document: Direct-to-Consumer Prescription Drug Advertisements:...
Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format Final Rule Questions and Answers